S
MRK icon

SignatureFD’s Merck MRK Stock Holding History

SignatureFD’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.9M Buy
57,399
+5,990
+12% +$692K 0.11% 71
2025
Q4 		$5.41M Buy
51,409
+4,644
+10% +$436K 0.08% 86
2025
Q3 		$3.92M Buy
46,765
+880
+2% +$72.5K 0.06% 118
2025
Q2 		$3.63M Sell
45,885
-5,064
-10% -$403K 0.06% 122
2025
Q1 		$4.57M Sell
50,949
-2,398
-4% -$224K 0.09% 82
2024
Q4 		$5.31M Sell
53,347
-2,013
-4% -$208K 0.1% 66
2024
Q3 		$6.29M Sell
55,360
-3,782
-6% -$449K 0.12% 56
2024
Q2 		$7.32M Buy
59,142
+3,826
+7% +$493K 0.15% 53
2024
Q1 		$7.3M Buy
55,316
+2,478
+5% +$305K 0.15% 54
2023
Q4 		$5.76M Buy
52,838
+3,891
+8% +$404K 0.13% 56
2023
Q3 		$5.04M Buy
48,947
+45
+0.1% +$4.85K 0.13% 59
2023
Q2 		$5.64M Buy
48,902
+272
+0.6% +$30.9K 0.14% 57
2023
Q1 		$5.17M Buy
48,630
+2,527
+5% +$273K 0.14% 56
2022
Q4 		$5.12M Buy
46,103
+3,186
+7% +$326K 0.15% 49
2022
Q3 		$3.7M Buy
42,917
+1,758
+4% +$157K 0.13% 59
2022
Q2 		$3.75M Buy
41,159
+3,473
+9% +$308K 0.13% 59
2022
Q1 		$3.09M Buy
37,686
+5,093
+16% +$402K 0.09% 69
2021
Q4 		$2.5M Sell
32,593
-11
-0% -$876 0.08% 90
2021
Q3 		$2.45M Buy
32,604
+3,068
+10% +$233K 0.08% 86
2021
Q2 		$2.3M Sell
29,536
-1,689
-5% -$126K 0.09% 84
2021
Q1 		$2.3M Sell
31,225
-731
-2% -$53.9K 0.1% 76
2020
Q4 		$2.49M Sell
31,956
-5,403
-14% -$413K 0.12% 65
2020
Q3 		$2.96M Buy
37,359
+8,818
+31% +$691K 0.16% 50
2020
Q2 		$2.11M Sell
28,541
-563
-2% -$42.4K 0.13% 62
2020
Q1 		$2.14M Buy
29,104
+2,112
+8% +$166K 0.18% 49
2019
Q4 		$2.34M Buy
26,992
+1,700
+7% +$140K 0.17% 49
2019
Q3 		$2.03M Buy
25,292
+2,787
+12% +$223K 0.17% 48
2019
Q2 		$1.8M Buy
22,505
+1,105
+5% +$84.6K 0.16% 50
2019
Q1 		$1.7M Sell
21,400
-3,325
-13% -$249K 0.14% 55
2018
Q4 		$1.8M Buy
24,725
+2,067
+9% +$146K 0.17% 51
2018
Q3 		$1.53M Buy
22,658
+1,221
+6% +$77.8K 0.16% 63
2018
Q2 		$1.24M Buy
21,437
+3,993
+23% +$225K 0.14% 69
2018
Q1 		$907K Sell
17,444
-1,614
-8% -$87.2K 0.11% 69
2017
Q4 		$1.02M Buy
19,058
+1,480
+8% +$82K 0.12% 69
2017
Q3 		$1.07M Buy
17,578
+157
+0.9% +$9.52K 0.14% 49
2017
Q2 		$1.06M Buy
17,421
+1,036
+6% +$63.1K 0.15% 49
2017
Q1 		$993K Buy
16,385
+560
+4% +$34K 0.15% 52
2016
Q4 		$889K Sell
15,825
-1,690
-10% -$98.9K 0.15% 51
2016
Q3 		$1.04M Buy
17,515
+3,139
+22% +$184K 0.15% 45
2016
Q2 		$790K Buy
14,376
+3,041
+27% +$162K 0.12% 45
2016
Q1 		$572K Buy
11,335
+2,025
+22% +$99.2K 0.1% 60
2015
Q4 		$469K Buy
9,310
+387
+4% +$19.5K 0.09% 65
2015
Q3 		$420K Buy
8,923
+2,199
+33% +$117K 0.1% 66
2015
Q2 		$365K Buy
6,724
+212
+3% +$11.9K 0.08% 96
2015
Q1 		$357K Buy
6,512
+258
+4% +$14.6K 0.09% 93
2014
Q4 		$339K Buy
6,254
+282
+5% +$15.7K 0.08% 95
2014
Q3 		$338K Sell
5,972
-702
-11% -$39.4K 0.11% 83
2014
Q2 		$368K Buy
6,674
+4,461
+202% +$243K 0.13% 68
2014
Q1 		$120K Buy
2,213
+143
+7% +$7.41K 0.05% 109
2013
Q4 		$99K Buy
2,070
+1,115
+117% +$51K 0.04% 134
2013
Q3 		$43K Sell
955
-117
-11% -$5.34K 0.02% 224
2013
Q2 		$48K Buy
+1,072
New +$47.9K 0.02% 175

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SignatureFD's MRK Position: Q1 2026 in Review

SignatureFD increased its Merck (MRK) stake by 12% in Q1 2026, buying an estimated $692K and bringing the position to 57,399 shares worth $6.9M. The position accounts for 0.11% of the portfolio, ranked #71.

SignatureFD first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $7.32M in Q2 2024. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • SignatureFD held 57,399 shares of Merck worth $6.9M as of Q1 2026.
  • SignatureFD bought 5,990 Merck shares in Q1 2026, an estimated $692K.
  • Merck made up 0.11% of SignatureFD's portfolio in Q1 2026, its #71 holding.
  • SignatureFD first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • SignatureFD's Merck position peaked at $7.32M in Q2 2024.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.